News Release
Puma Biotechnology: A Speculative Investment At A Discount (NASDAQ:PBYI) | Seeking Alpha
Stocks to Watch: Dropbox, Nike, Tronc, Qualcomm, Puma Biotechnology, Invitation Homes, Universal Display - WSJ
Articles with Puma Biotechnology
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Is Puma Biotechnology (PBYI) Stock a Solid Choice Right Now?
Puma Biotechnology falls more than 20%
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Video Puma Biotechnology Soars on Breast Cancer Drug Results - ABC News
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Puma Biotechnology (PBYI) Stock Climbs On Orphan Drug Designation | Alpha Stock News
Supernus, Puma Among 5 Big Biotech Stock Winners, Losers Monday | Stock News & Stock Market Analysis - IBD
Puma Biotech News, Puma Biotech Quote, PBYI Quote - StreetInsider.com
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Why Puma Biotechnology Is Soaring Today | The Motley Fool
PBYI Institutional Ownership and Shareholders - Puma Biotechnology Inc (NASDAQ) Stock
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
Puma Biotechnology (PBYI) Q1 Earnings: Stock To Disappoint? | Investing.com
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
